新华制药：董事徐列辞职

Group 1 - The core point of the article is the resignation of Xu Lie from the board of directors and the strategic development committee of Shandong Xinhua Pharmaceutical Co., Ltd. due to age reasons, effective March 31, 2026 [1] - Xu Lie will not hold any position in the company after his resignation [1] Group 2 - The article also mentions a separate investigation into the performance of an AI stock trading tool, with reports of significant gains and losses among users, highlighting the volatility and risks associated with such investment strategies [1]